Sign inJoin waitlistJoin the waitlist

Eudocia Lee

Physician · Dana-Farber Cancer Institute

Credentials: · · ·

History

Dana-Farber Cancer Institute
Present

Mass General Brigham
2003–2007
Washington University School of Medicine
1999–2003

Research

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Nature Medicine · 2019 · 1,142 citations
Epidemiology of brain metastases
Current Oncology Reports · 2012 · 1,074 citations
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Review · Neuro-Oncology · 2020 · 995 citations

PW
Patrick Wen
111 papers
David Reardon
55 papers
Lakshmi Nayak
47 papers
BA
Brian Alexander
34 papers
Keith Ligon
32 papers
Rameen Beroukhim
30 papers
Tracy Batchelor
29 papers
Ugonma Chukwueke
28 papers
Andrew Norden
27 papers · 4 as a fellow
Jan Drappatz
22 papers
Ayal Aizer
21 papers · 4 as a resident
Susan Chang
20 papers

Clinical trials

Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer
Principal investigator · Terminated · Phase 1
National Cancer Institute (NCI)
2018–2025
Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma
Principal investigator · Completed · Phase 2
Dana-Farber Cancer Institute
2015–2018
Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma
Principal investigator · Terminated · Phase 1
National Cancer Institute (NCI)
2014–2023
Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
2013–2024